Shen Yao Selected Research

Shen Yao Research Topics

Disease

17	Neoplasms (Cancer) 02/2024 - 12/2002
12	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 01/2002
3	Atrophy 05/2024 - 10/2011
3	Uveitis 12/2023 - 11/2021
3	Neoplasm Metastasis (Metastasis) 12/2016 - 04/2010
2	Ischemic Stroke 01/2018 - 12/2017
2	Hypoxia (Hypoxemia) 02/2005 - 12/2002
1	Anterior Uveitis 12/2023
1	Endophthalmitis (Ophthalmia) 12/2023
1	Erectile Dysfunction 12/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Wounds and Injuries (Trauma) 11/2018
1	Myocardial Infarction 08/2018
1	Stroke (Strokes) 12/2017
1	Type 2 Diabetes Mellitus (MODY) 11/2016
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Sarcopenia 10/2011
1	Sarcoma (Soft Tissue Sarcoma) 05/2011
1	Carcinoma (Carcinomatosis) 01/2011
1	Osteoporosis 04/2010
1	Ovarian Epithelial Carcinoma 06/2006
1	Inflammation (Inflammations) 01/2002
1	Prostatic Intraepithelial Neoplasia 01/2002
1	Carcinogenesis 01/2002

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 06/2017 - 02/2005
4	ProstaglandinsIBA 04/2010 - 01/2002
3	AndrogensIBA 01/2018 - 06/2007
3	Dinoprostone (PGE2)FDA Link 04/2010 - 12/2002
3	Prostaglandins EIBA 04/2010 - 01/2002
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2005 - 01/2002
2	Neutralizing AntibodiesIBA 01/2022 - 11/2021
2	Air Pollutants (Pollutants, Air)IBA 08/2018 - 01/2018
2	Androgen Receptors (Androgen Receptor)IBA 01/2018 - 06/2014
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 06/2017 - 01/2011
2	prostatic acid phosphataseIBA 12/2016 - 11/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 06/2006
2	Nandrolone (Nortestosterone)IBA 11/2012 - 10/2011
2	Anabolic Androgenic SteroidsIBA 11/2012 - 10/2011
2	Protein Isoforms (Isoforms)IBA 06/2006 - 07/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2006 - 12/2002
2	Arachidonic Acid (Vitamin F)IBA 02/2005 - 12/2002
2	EnzymesIBA 02/2005 - 12/2002
1	Testosterone (Sustanon)FDA Link 05/2024
1	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2024
1	VimentinIBA 02/2024
1	CytokinesIBA 12/2023
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 12/2022
1	Therapeutic UsesIBA 12/2022
1	triptolideIBA 12/2022
1	MicellesIBA 12/2022
1	Lipid NanoparticlesIBA 01/2022
1	norcantharidinIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	alanyl-prolyl-arginyl-prolyl-glycineIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Aurora Kinase BIBA 12/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2021
1	AntibodiesIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	SmokeIBA 11/2018
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2018
1	enzalutamideIBA 01/2018
1	OzoneIBA 12/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2017
1	Phosphotransferases (Kinase)IBA 06/2017
1	RANK LigandIBA 12/2016
1	OsteoprotegerinIBA 12/2016
1	Hexachlorocyclohexane (gamma-Hexachlorocyclohexane)FDA LinkGeneric 11/2016
1	AdiponectinIBA 11/2016
1	Notch ReceptorsIBA 11/2012
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2011
1	CateninsIBA 05/2011
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2011
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2011
1	Codon (Codons)IBA 01/2011
1	Ribosome Inactivating ProteinsIBA 08/2009
1	Histones (Histone)IBA 08/2009
1	Histone Deacetylase InhibitorsIBA 08/2009
1	Tumor Viral Antigens (Large T Antigen)IBA 03/2008
1	SteroidsIBA 02/2006
1	Small Interfering RNA (siRNA)IBA 07/2005
1	Proto-Oncogene Proteins c-mdm2IBA 02/2005
1	EicosanoidsIBA 02/2005
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2005
1	Messenger RNA (mRNA)IBA 12/2002
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2002
1	Interleukin-6 (Interleukin 6)IBA 01/2002

Therapy/Procedure

4	Therapeutics 12/2021 - 11/2011
2	Intravitreal Injections 12/2023 - 01/2022
2	Denervation 11/2012 - 10/2011
1	Immunotherapy 01/2021
1	Castration 01/2018
1	Drug Therapy (Chemotherapy) 01/2016
1	Prostatectomy (Retropubic Prostatectomy) 02/2006